Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128828 · ClinicalTrials.gov registry record · Phase 2
Effect of Cenicriviroc on HIV Neurocognitive Impairment
A Phase 2 study, sponsored by University of Hawaii.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02128828 is a Phase 2 study that has completed, run by University of Hawaii. The registered enrollment target is 20 participants.
The verdict
NCT02128828, a Phase 2 study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The study hypothesis is that cenicriviroc will improve cognition in HIV infected individuals with cognitive impairment. The investigators will study the effect of cenicriviroc on cognition in 24 subjects over a 24 week period.
Interventions
- DRUG cenicriviroc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02128828
The ClinicalTrials.gov registry entry for NCT02128828 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cenicriviroc is the first listed.
NCT02128828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02128828 about?
NCT02128828 is a clinical study titled "Effect of Cenicriviroc on HIV Neurocognitive Impairment". The study hypothesis is that cenicriviroc will improve cognition in HIV infected individuals with cognitive impairment. The investigators will study the effect of cenicriviroc on cognition in 24 subjects over a 24 week period.
What is the current status of trial NCT02128828?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2014-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02128828?
The interventions under investigation include: cenicriviroc (DRUG).
Who is sponsoring clinical trial NCT02128828?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.